For the 2016-2017 academic year, the 4 stipends below have been awarded:
- Mr. Hedde Biesma, promovendus, VU
Institute: John Wayne Cancer Institute, Santa Monica, USA
Research: Towards precision medicine for gastric cancer patients: identification of methylation markers for prognosis and response prediction - Ms. Sophie Dusoswa, physician-researcher, VU
Institute: Harvard Medical School Neuroscience Center, Boston, USA
Research: The contribution of carbohydrate‐dependent interactions in glioblastoma immune escape: new targets for check‐point inhibition? - Mr. Roeland Lameris, promovendus, VU
Institute: Monash University, Dept. Biochemistry and Molecular Biology, Clayton, Victoria, Australië
Research: Structural analyses to explain the differential antitumor efficacy f a unique set of CD1dspecific nanobodies - Ms. Hagma Workel, promovendus, UMCG
Institute: Oxford Centre for Cancer Gene Research, Oxford, UK
Research: Naar een beter begrip van T cel specifieke migratie naar het epitheel van gynaecologische maligniteiten: het ontrafelen van de tumor postcode